The group will operate on the market as two distinct networks, called Novasep Synthesis and Novasep Process. The former will provide R&D services and custom synthesis, from the laboratory to industrial scale, with the combined expertise of the following business lines: Dynamit Nobel (specialized in hazardous chemistry), Rohner (transition metal catalysis), Finorga (experts in chiral chemistry) and Séripharm (specialized in high potency products).
Meanwhile, Novasep Process will offer research and purification solutions based on chromatography, ion exchange, membranes, crystallization and downstream bioprocesses, and its network will include Novasep SAS (chromatography and crystallisation solutions for pharmaceutical companies), Applexion (chromatography, ion exchange for the foods and biotech markets) and Orelis (specialising in cross-flow filtration).
Roger Marc-Nicoud, Groupe Novasep's president and founder, said the new structure would 'maximize synergies between the resources of the group, give customers access to all the resources of the group via a single local contact, and keep the local management empowered to ensure an entrepreneurial and reactive behaviour'.
"In the life science market today, customers demand higher purity levels, cost-efficient solutions, strict regulatory and operational controls and shorter times to market," he said.
A new logo (pictured) has been designed to represent all the business lines and activities of the group.